US Department of Health and Human Services (HHS) - Patent US6630507B1

"Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidiol, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. A particular disclosed class of cannabinoids useful as neuroprotective antioxidants is formula (I) wherein the R group is independently selected from the group consisting of H, CH3, and COCH3."

Hemoscreen™ Summary

(Cannabinoid Blood Tests)

Radioligand Binding Summary

(CB1/CB2 receptor binding affinity of cannabinoids)

Cultivated Seed Lot

Material Harvest Sheet

Safety Data Sheet

Seed Purchase Specs

Certificate Of Analysis

Certificate of Origin